TransMedics Group Inc (TMDX) Stock Analysis

TransMedics Group Inc (TMDX) is a publicly traded company in the HEALTHCARE sector. It trades at $68.45, carries a market capitalization of $2.33B, a price-to-earnings ratio of 15.45. This page summarizes the public market data, fundamentals, and frequently asked questions for TMDX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $68.45
• Market Cap: $2.33B
• P/E Ratio: 15.45
• EPS: $4.37
• 52-Week High: $156.00
• 52-Week Low: $60.10

Market Sentiment

TransMedics Group Inc currently has a Bullish sentiment score of 0.17.

About TransMedics Group Inc

TransMedics Group, Inc. (TMDX) is an innovative medical technology company headquartered in Andover, Massachusetts, dedicated to transforming organ transplant therapy for patients with end-stage organ failure. The company has developed the proprietary Organ Care System, which significantly improves the preservation and optimization of donor organs, ultimately enhancing patient outcomes and expanding transplant viability. As a commercial-stage organization, TransMedics is strategically positio...

GNG Research Analysis

GNG Research scores TransMedics Group Inc (TMDX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TMDX.

Frequently Asked Questions

Does TMDX pay dividends?

TransMedics Group Inc (TMDX) does not currently pay a regular dividend.

What is TMDX's P/E ratio?

TransMedics Group Inc has a price-to-earnings (P/E) ratio of 15.45.

What is TMDX's market cap?

TransMedics Group Inc (TMDX) has a market capitalization of $2.33B with a current stock price of $68.45.